Ultime prove


EudraCT Number: 2006-000476-33 Sponsor Protocol Number: GC-SU-2006 Start Date: 2006-11-20
Sponsor Name: Johannes-Gutenberg-Universität Mainz, I. Medizinische Klinik und Poliklinik
Full Title: An open-label, multicenter phase II trial of Sunitinib for patients with chemo-refractory metastatic gastric cancer
Medical condition: Chemorefractory metastatic adenocarcinoma of stomach, esophagogastric junction and lower esophagus (Barrett carcinoma)
Disease: Version SOC Term Classification Code Term Level
8.1 10017758 Gastric cancer LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2006-004882-32 Sponsor Protocol Number: BY1023/NL511 Start Date: 2006-11-20
Sponsor Name: ALTANA Pharma bv
Full Title: Evaluation of clinical endpoints for treatment-induced changes in GERD-related symptoms
Medical condition: gastroesophageal reflux disease (GERD) or Non Erosive Reflux Disease (NERD)
Disease: Version SOC Term Classification Code Term Level
8.1 10017885 Gastrooesophageal reflux disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: View results
EudraCT Number: 2006-002052-15 Sponsor Protocol Number: SPD490-301 Start Date: 2006-11-20
Sponsor Name: Shire
Full Title: An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients with Anaemia Asso...
Medical condition: Anaemia in Chronic Kidney Disease (CKD)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Prematurely Ended) BE (Completed) AT (Prematurely Ended) FR (Completed) DE (Prematurely Ended) IT (Prematurely Ended) LT (Prematurely Ended) LV (Prematurely Ended) HU (Completed)
Trial results: View results

EudraCT Number: 2006-002403-13 Sponsor Protocol Number: Ularitide-1502 Start Date: 2006-11-20
Sponsor Name: PDL BioPharma Inc
Full Title: A Phase 3, Randomized, Double-blinded, Placebo-controlled Study of Ularitide in the Treatment of Subjects with Acute Decompensated Heart Failure
Medical condition: Acute decompensated heart failure
Disease: Version SOC Term Classification Code Term Level
8.1 10000803 Acute heart failure LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Prematurely Ended) LT (Prematurely Ended) AT (Temporarily Halted)
Trial results: (No results available)
EudraCT Number: 2006-000687-89 Sponsor Protocol Number: ICR-CTSU/2008/10018 Start Date: 2006-11-20
Sponsor Name: Institute of Cancer Research
Full Title: A randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder
Medical condition: Non-muscle Invasive Transitional cell Carcinoma of the Bladder
Disease: Version SOC Term Classification Code Term Level
20.0 100000004864 10005004 Bladder cancer NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)

EudraCT Number: 2006-004749-40 Sponsor Protocol Number: PEDMet 2006-1 Start Date: 2006-11-20
Sponsor Name: Pediatrics
Full Title: Glucose metabolism in patients with neurological/neuromuscular diseases.
Medical condition: Patients with neurological/neuromuscular diseases
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: BE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-004722-82 Sponsor Protocol Number: CSTI571E2204 Start Date: 2006-11-20
Sponsor Name: Novartis Pharma Services AG
Full Title: An exploratory study of the effects of Imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to T...
Medical condition: Seasonal Allergic Rhinitis (sensitivity to Timothy grass pollen)
Disease: Version SOC Term Classification Code Term Level
8.1 10039776 Seasonal allergic rhinitis LLT
Population Age: Adults Gender: Male
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2006-004516-51 Sponsor Protocol Number: GEN112 Start Date: 2006-11-20
Sponsor Name: Genmab A/S
Full Title: A multicentre open-label, dose-escalation, trial of zanolimumab in combination with CHOP chemotherapy in subjects with CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement
Medical condition: CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement
Disease: Version SOC Term Classification Code Term Level
8.1 10034624 Peripheral T-cell lymphoma unspecified NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Prematurely Ended) DE (Completed) IT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-004735-30 Sponsor Protocol Number: IH 003 Start Date: 2006-11-20
Sponsor Name: Ineos Healthcare Ltd
Full Title: An open label, dose-ranging study to establish the tolerability of Alpharen™ in haemodialysis subjects with hyperphosphataemia.
Medical condition: Hyperphosphataemia in haemodialysis subjects
Disease: Version SOC Term Classification Code Term Level
8.1 10020711 Hyperphosphataemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)

EudraCT Number: 2006-003409-18 Sponsor Protocol Number: RRC-2/3-2006 Start Date: 2006-11-20
Sponsor Name: Sahlgrenska University Hospital, Östra
Full Title: An Open-label, Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 weeks pegylated interferon alfa-2a 40 kD (PEGASYS®) Combination Therapy with Ribavirin (Copegus®) in Patients with Ch...
Medical condition: chronic hepatitis C (CHC) virus infection genotype 2 or 3 who responded during (i.e. had HCV-RNA
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Ongoing) DK (Completed) FI (Completed)
Trial results: (No results available)
3